Related references
Note: Only part of the references are listed.In Vitro pH Activity of Ibrexafungerp against Fluconazole-Susceptible and -Resistant Candida Isolates from Women with Vulvovaginal Candidiasis
Jack D. Sobel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Vaginitis in Nonpregnant Patients
Jorma A. Paavonen et al.
OBSTETRICS AND GYNECOLOGY (2020)
Oral Ibrexafungerp: an investigational agent for the treatment of vulvovaginal candidiasis
Nkechi Azie et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
A Novel 1,3-Beta-D-Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis
E. L. Larkin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies
Anick Berard et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2019)
Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents
Sahar Hasim et al.
FUTURE MEDICINAL CHEMISTRY (2019)
SCY-078, a Novel Fungicidal Agent, Demonstrates Distribution to Tissues Associated with Fungal Infections during Mass Balance Studies with Intravenous and Oral [14C] SCY-078 in Albino and Pigmented Rats
Stephen Wring et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
A phase 2b, dose-selection study evaluating the efficacy and safety of oral ibrexafungerp vs fluconazole in vulvovaginal candidiasis (DOVE)
D. Angulo et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2019)
CD101 Topical Compared With Oral Fluconazole for Acute Vulvovaginal Candidiasis: A Randomized Controlled Trial
Paul Nyirjesy et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2019)
An Update on the Roles of Non-albicans Candida Species in Vulvovaginitis
Olufunmilola Makanjuola et al.
JOURNAL OF FUNGI (2018)
SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies
Bernard Scorneaux et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Recurrent vulvovaginal candidiasis
Jack D. Sobel
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis
Xiaofang Zhou et al.
MYCOSES (2016)
Miconazole Nitrate Vaginal Suppository 1,200 mg versus Oral Fluconazole 150 mg in Treating Severe Vulvovaginal Candidiasis
Shangrong Fan et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2015)
A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis
Ting Li et al.
MEDICAL MYCOLOGY (2015)
Guideline: Vulvovaginal Candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis)
Werner Mendling
MYCOSES (2015)
Use of Oral Fluconazole during Pregnancy and the Risk of Birth Defects
Ditte Molgaard-Nielsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Oral fluconazole 150mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis
Leila Sekhavat et al.
Journal of Infection and Public Health (2011)
Treatment of complicated Candida vaginitis:: Comparison of single and sequential doses of fluconazole
JD Sobel et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2001)
Share Paper
